Skip to main content
. 2020 Sep 1;123(10):1496–1501. doi: 10.1038/s41416-020-01033-x

Table 1.

Toxicity categories used in the phase I study reports examined, as per the Common Terminology Criteria for Adverse Events, version 4.0.

Toxicity category Common human toxicities Common animal toxicities
Cardiovascular Hypertension, tachycardia, bradycardia, dyslipidemia Tachycardia, bradycardia
Cutaneous Rash, alopecia Rash, fur discoloration
Endocrine Diabetes Increase in endocrine system organs
Gastrointestinal Nausea, vomiting, diarrhoea Loose stool
General Fatigue, fever, chills Decreased activity
Haematologic Neutropenia, thrombocytopenia Changes in red blood cells or white blood cells
Hepatic Changes in alanine transaminase or aspartate transaminase Changes in alanine transaminase or aspartate transaminase
Metabolic Anorexia, decreased appetite, hyperglycaemia Decreased food consumption
Musculoskeletal Muscle pain, back pain Awkward gait, hunched posture
Neurologic/psychiatric Headache, insomnia Tremors
Ocular Blurred vision Bloody tears
Renal Changes in creatinine or blood urea nitrogen Blood in urine
Respiratory Cough, shortness of breath Laboured breathing